| Size | Price | Stock | Qty |
|---|---|---|---|
| 5mg |
|
||
| 10mg |
|
||
| Other Sizes |
|
| Targets |
EC50: 10.5 μM (Ca2+ current response from TPC2)[1]
|
|---|---|
| ln Vitro |
Ancient members of the voltage-gated ion channel superfamily are known as two-pore channels (TPC1-3). The endo-lysosomal system expresses TPCs, which control the trafficking of different payloads. Depending on how it is triggered, TPC2 can mediate various physiological and potentially pathological effects. TPC2's ion selectivity is agonist-dependent rather than fixed. One special type of ion channel that responds to various activating ligands by conducting distinct ions is TPC2. Ca2+ signals are consistently evoked by TPC2-A1-N (10 μM), and the response reaches its plateau more quickly in TPC2-A1-N than in TPC2-A1-P. TPC2-A1-N has an EC50 of 7.8 μM in full concentration-effect relationships for the plateau response in a cell line that is stable in expressing TPC2L11A/L12A. Cells expressing TPC2L11A/L12A are activated by TPC2-A1-N (10 μM) to induce Ca2+ influx through the TPC2 pore, but not TPC2L11A/L12A/L265P. Furthermore, by removing extracellular Ca2+, the known TPC2 blockers Tetrandrine (Tet), Raloxifene (Ral), and Fluphenazine (Flu) can specifically prevent the reactions to TPC2-A1-N[1]. TPC2-A1-N (30 μM) elicits currents using Na+ as the main permeation in endo-lysosomal patch-clamp tests conducted on vacuolin-enlarged endo-lysosomes derived from HEK293 cells transiently expressing human TPC2 (hTPC2), but not in cells expressing TPC1[1]. TPC2-A1-N (30 μM) causes more currents in endo-lysosomes isolated from cells expressing a gain-of-function variation of TPC2 (TPC2M484L) than in the wild-type isoform in endo-lysosomal patch-clamp experiments. TPC2-A1-N has an EC50 value of 0.6 μM[1].
|
| References |
[1]. Susanne Gerndt, et al. Agonist-mediated switching of ion selectivity in TPC2 differentially promotes lysosomal function. Elife
[2]. Xuhui Jin, et al. Targeting Two-Pore Channels: Current Progress and Future Challenges. Trends Pharmacol Sci. 2020 Aug;41(8):582-594. |
| Molecular Formula |
C17H9CL2F3N2O2
|
|---|---|
| Molecular Weight |
401.17
|
| CAS # |
136186-07-7
|
| SMILES |
ClC1C=C(C=C(C=1)/C(=C(\C#N)/C(NC1C=CC(C(F)(F)F)=CC=1)=O)/O)Cl
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO: 250 mg/mL (623.18 mM)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.08 mg/mL (5.18 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.08 mg/mL (5.18 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C，1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. View More
Solubility in Formulation 3: ≥ 2.08 mg/mL (5.18 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.4927 mL | 12.4635 mL | 24.9271 mL | |
| 5 mM | 0.4985 mL | 2.4927 mL | 4.9854 mL | |
| 10 mM | 0.2493 mL | 1.2464 mL | 2.4927 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
